BSE filing, NSE: GENUSPAPER. Summary written from the filing by ALFA Finder's alert engine.
Genus Paper & Boards Ltd: key numbers
- Share price
- ₹10.14
- Market cap
- ₹260.7 Cr
- Revenue (annual)
- ₹940.0 Cr
- Net profit (annual)
- ₹14.58 Cr
- P/E (TTM)
- 18.7×Sector 36.4×
- Promoter holding
- 50.84%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Genus Paper & Boards Ltd
All →Genus Paper & Boards Board Meeting Date
Genus Paper & Boards Ltd has scheduled a board meeting on October 29, 2026, to consider and approve unaudited financial results for the quarter ended September 30.
Genus Paper & Boards Annual General Meeting
Genus Paper & Boards Ltd held its 15th Annual General Meeting on September 25, 2026. All proposed business resolutions were approved by shareholders.
Genus Paper & Boards Promoter Buying (Off-Market)
Promoter group entity Hi-Print Electromack acquired 80.39 lakh shares of Genus Paper & Boards from fellow promoter group firms through an inter-se transfer.
Genus Paper & Boards Annual Report
Genus Paper & Boards Ltd submitted its Annual Report for FY 2025-26. The company scheduled its 15th Annual General Meeting for September 25, 2026.
Genus Paper & Boards Annual General Meeting
Genus Paper & Boards Ltd announced its 15th Annual General Meeting will be held on September 25, 2026, via video conferencing.
Genus Paper & Boards Q1 FY27 Results: Net Profit ₹3.5 Cr, Down 16.7% YoY
Genus Paper & Boards Ltd reported revenue from operations of ₹218.7 Cr (-12.7% YoY) and net profit of ₹3.5 Cr (-16.7% YoY) for Q1 FY27.
- Key figure
- Net profit ₹3.5 Cr · -16.7% YoY
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.